Biotech

All Articles

Lykos will definitely ask FDA to reexamine its own selection observing rejection of MDMA therapy for post-traumatic stress disorder

.Following an unsatisfactory revealing for Lykos Therapeutics' MDMA candidate for post-traumatic str...

AN 2 one-halfs census, quits stage 3 trial after data disappoint

.AN2 Therapeutics is re-thinking its organization in response to uninspired midphase information, pr...

Merck pays for $700M for bispecific, snooping autoimmune position and also possibility to test Amgen in cancer

.Merck &amp Co. is actually spending $700 million in advance to test Amgen in a blood cancer cells m...

Gilead pays J&ampJ $320M to go out licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA choice for its liver condition medicine seladelpar, the pr...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks can find the business setting up outdoors tents at basecamp responsible for Eli Lil...

Entero laying off workers, leaving workplace and stopping R&ampD

.Mattress Liquidators has actually transformed Entero Rehabs white colored as a slab. The creditor b...

Exelixis falls ADC after deciding it's no suit for Tivdak

.Exelixis is losing hope on its own cells aspect (TF)- targeting antibody-drug conjugate after endin...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three weeks after Roche's Genentech device ignored an SHP2 inhibitor deal, Relay Therapeutics has a...

Stoke's Dravet syndrome med launched of predisposed medical hold

.Stoke Therapies' Dravet syndrome medication has been freed from a predisposed hold, removing the te...

Fierce Biotech's Gabrielle Masson offers Fierce 15 at NYSE

.Brutal Biotech Colleague Publisher Gabrielle Masson presented the 2024 training class of Tough 15 c...